Related Experiment Video
Updated: May 3, 2026

Bone Conditioned Medium: Preparation and Bioassay
Published on: July 8, 2015
Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation
W Gu1, J W Schneider, G Condorelli
1Howard Hughes Medical Institute, Children's Hospital, Boston, Massachusetts 02115.
Abstract:
The experiments reported here document that the tumor suppressor retinoblastoma protein (pRB) plays an important role in the production and maintenance of the terminally differentiated phenotype of muscle cells. We show that pRB inactivation, through either phosphorylation, binding to T antigen, or genetic alteration, inhibits myogenesis. Moreover, inactivation of pRB in terminally differentiated cells allows them to reenter the cell cycle. In addition to its involvement in the myogenic activities of MyoD, pRB is also required for the cell growth-inhibitory activity of this myogenic factor. We also show that pRB and MyoD directly bind to each other, both in vivo and in vitro, through a region that involves the pocket and the basic-helix-loop-helix domains, respectively. All the results obtained are consistent with the proposal that the effects of MyoD on the cell cycle and of pRB on the myogenic pathway result from the direct binding of the two molecules.
Insights
The retinoblastoma protein (pRB) is crucial for muscle cell differentiation and maintenance. Its inactivation inhibits muscle development and allows differentiated cells to re-enter the cell cycle, highlighting pRB's role in cell cycle control.
Area of Science:
- Molecular Biology
- Cell Biology
- Developmental Biology
Background:
- The tumor suppressor retinoblastoma protein (pRB) is a key regulator of cell proliferation.
- Muscle differentiation (myogenesis) involves complex regulatory pathways controlling cell fate.
- Myogenic factors like MyoD initiate and drive the differentiation process.
Purpose of the Study:
- To investigate the role of the retinoblastoma protein (pRB) in muscle cell differentiation (myogenesis).
- To determine how pRB inactivation affects the terminally differentiated state of muscle cells.
- To elucidate the interaction between pRB and the myogenic factor MyoD.
Main Methods:
- Studied pRB inactivation through phosphorylation, T antigen binding, and genetic alteration.
- Assessed the impact of pRB inactivation on myogenesis.
- Analyzed the ability of terminally differentiated cells to re-enter the cell cycle.
- Investigated the physical binding between pRB and MyoD in vivo and in vitro.
Main Results:
- pRB inactivation, via various mechanisms, significantly inhibits myogenesis.
- Inactivated pRB in differentiated muscle cells promotes cell cycle re-entry.
- pRB is essential for the cell growth-inhibitory function of MyoD.
- Direct binding between pRB and MyoD was confirmed through in vivo and in vitro experiments, involving specific protein domains.
Conclusions:
- pRB is vital for establishing and maintaining the terminally differentiated muscle cell phenotype.
- The interaction between pRB and MyoD is critical for regulating both cell cycle progression and myogenic differentiation.
- These findings reveal a direct molecular link between pRB's cell cycle control and MyoD's differentiation pathways.
Related Concept Videos
Paracrine Signaling
Bone Remodeling
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Anchoring Junctions
The Bone Matrix
Microscopic Anatomy of Skeletal Muscles
The muscle sarcolemma is a plasma membrane enclosing each muscle cell that conducts electrical signals called action potentials. The sarcolemma extends into the cell to form T-tubules, ensuring the neural impulses are uniformly distributed across the entire muscle...

